Non-alcoholic steatohepatitis in patients cared in metabolic units

Diabetes Research and Clinical Practice

Volumn 63, Issue 2, 2004, Pages 143-151

  Marchesini, Giulio ^a   Bugianesi, Elisabetta ^b   Forlani, Gabriele ^a   Marzocchi, Rebecca ^a   Zannoni, Chiara ^a   Vanni, Ester ^b   Manini, Rita ^a   Rizzetto, Mario ^b   Melchionda, Nazario ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Diabetes, non insulin dependent; Fatty liver; Hyperlipidemia; Metabolic syndrome X; Obesity

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FATTY LIVER; FEMALE; FOLLOW UP; HEPATITIS; HUMAN; HYPERLIPIDEMIA; LIVER BIOPSY; LIVER DISEASE; LIVER FAILURE; LIVER FIBROSIS; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; OBESITY; PREVALENCE; STEATOHEPATITIS;

EID: 0347301651     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2003.09.007     Document Type: Article

References (44)

1. Bacon B.R., Farahvash M.J., Janney C.G., Neuschwander-Tetri B.A. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 107:1994;1103-1109.
2. Diehl A.M., Goodman Z., Ishak K.G. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 95:1988;1056-1062.
3. Powell E.E., Cooksley W.G., Hanson R., Searle J., Halliday J.W., Powell L.W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 11:1990;74-80.
4. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 116:1999;1413-1419.
5. Poonawala A., Nair S.P., Thuluvath P.J. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology. 32:2000;689-692.
6. Bugianesi E., Leone N., Vanni E.et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 123:2002;134-140.
7. Clark J.M., Brancati F.L., Diehl A.M. Nonalcoholic fatty liver disease. Gastroenterology. 122:2002;1649-1657.
8. Nomura H., Kashiwagi S., Hayashi J., Kajiyama W., Tani S., Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn. J. Med. 27:1988;142-149.
9. Bellentani S., Tiribelli C., Saccoccio G.et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology. 20:1994;1442-1449.
10. Bellentani S., Saccoccio G., Masutti F.et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med. 132:2000;112-117.
11. P. Jepsen, H. Vilstrup, L. Mellemkjaer, et al., Prognosis of patients with a diagnosis of fatty liver - a registry-based cohort study, Hepato-gastroenterology (in press).
12. de Marco R., Locatelli F., Zoppini G., Verlato G., Bonora E., Muggeo M. Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care. 22:1999;756-761.
13. Bianchi G., Marchesini G., Zoli M., Bugianesi E., Fabbri A., Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology. 20:1994;119-125.
14. Ratziu V., Giral P., Charlotte F.et al. Liver fibrosis in overweight patients. Gastroenterology. 118:2000;1117-1123.
15. Marceau P., Biron S., Hould F.S.et al. Liver pathology and the metabolic syndrome X in severe obesity. J. Clin. Endocrinol. Metab. 84:1999;1513-1517.
16. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetes Med. 15:1998;539-553.
17. Marchesini G., Brizi M., Morselli-Labate A.M.et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107:1999;450-455.
18. Sanyal A.J., Campbell-Sargent C., Mirshahi F.et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 120:2001;1183-1192.
19. Marchesini G., Brizi M., Bianchi G.et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 50:2001;1844-1850.
20. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA 285 (2001) 2486-2497.
21. Saverymuttu S.H., Joseph A.E., Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br. Med. J. 292:1986;13-15.
22. Guidelines Subcommittee, 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension, J. Hypertens. 17 (1999) 151-183.
23. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from plasma fasting glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
24. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94:1999;2467-2474.
25. Angulo P., Keach J.C., Batts K.P., Lindor K.D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 30:1999;1356-1362.
26. Clark J.M., Brancati F.L., Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am. J. Gastroenterol. 98:2003;960-967.
27. Creutzfeldt W., Frerichs H., Sickinger K. Liver diseases and diabetes mellitus. Prog. Liver. Dis. 3:1970;371-407.
28. El-Serag H.B., Everhart J.E. Diabetes increases the risk of acute hepatic failure. Gastroenterology. 122:2002;1822-1828.
29. Caldwell S.H., Oelsner D.H., Iezzoni J.C., Hespenheide E.E., Battle E.H., Driscoll C.J. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 29:1999;664-669.
30. World Health Organization, Preventing and managing the global epidemic: report of a WHO consultation, World Health Organization, Geneva, 2000.
31. Wanless I.R., Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 12:1990;1106-1110.
32. Cortez-Pinto H., Camilo M.E., Baptista A., De Oliveira A.G., De Moura M.C. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin. Nutr. 18:1999;353-358.
33. Pagano G., Pacini G., Musso G.et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology. 35:2002;367-372.
34. Marchesini G., Bugianesi E., Forlani G.et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 37:2003;917-923.
35. Mofrad P., Contos M.J., Haque M.et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 37:2003;1286-1292.
36. Bonora E., Targher G., Alberiche M.et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 23:2000;57-63.
37. Day C.P., James O.F.W. Steatohepatitis: a tale of two "hits" Gastroenterology. 114:1998;842-845.
38. Tilg H., Diehl A.M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 343:2000;1467-1476.
39. Greenberg A.S., McDaniel M.L. Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur. J. Clin. Invest. 32(Suppl. 3):2002;24-34.
40. Palmer M., Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 99:1990;1408-1413.
41. Ueno T., Sugawara H., Sujaku K.et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J. Hepatol. 27:1997;103-107.
42. Luyckx F.H., Lefebvre P.J., Scheen A.J. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab. 26:2000;98-106.
43. Caldwell S.H., Hespenheide E.E., Redick J.A., Iezzoni J.C., Battle E.H., Sheppard B.L. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am. J. Gastroenterol. 96:2001;519-525.
44. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Zoli M., Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet. 358:2001;893-894.